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Abstract  
BACKGROUND: The incidence rate of diabetes mellitus has increased throughout the year. Various studies 
indicate that smoking may affect glucose metabolism and cause hyperglycemia in diabetes mellitus. This study 
aimed to compare the blood glucose and HbA1c level in diabetic smoking patients and non-smoking diabetic 
patients. 
METHODS: This study used the cross-sectional approach. The study population consisted of 30 diabetic smoking 
patients and 30 non-smoking diabetic patients. The diabetes history and the smoking status of the study 
population obtained by questionnaire-based interview, the blood glucose and HbA1c level were measured by 
hexokinase and immunoturbidimetry method using cobas 6000 analyser module c501  (Roche Diagnostics, 
Switzerland).  
RESULTS: The result in this study showed the fasting blood glucose, postprandial blood glucose, and HbA1c 
were higher by 23.64 mg/dl (p = 0.325), 58.00 mg/dl (p = 0.016), 0.39% (p = 0.412) in smoking diabetic patients 
compared to non-smoking diabetic patients. After statistical analysis, there was a significant difference (p < 0.05) 
of postprandial glucose level between smokers group and non-smokers group, but the non-significant difference 
of fasting blood glucose and HbA1c  
CONCLUSIONS: This study concluded that there was a significant difference in postprandial glucose level 
between smokers group and non-smokers group but the non-significant difference of fasting blood glucose and 
HbA1c. 
 
 
 
 
 
Introduction 
 
The incidence rate of Diabetes Mellitus (DM) 
has been increasing in every year in the worldwide. 
International Diabetes Federation estimates in 2015 
that 8.5% (equivalent to 78.3 million people) of the 
adult population in South-East Asia suffers from 
diabetes. In Indonesia, an increase in diabetes 
incidence has been noted, from 1.1% in 2007 to 2.1% 
in 2013 [1] [2]. Diabetes is a metabolic disorder 
characterised by the presence of chronic 
hyperglycemia. Hyperglycemia may be caused by 
insulin resistance syndrome, insulin deficiency, or 
both [3]. Diabetes can be diagnosed by biomarker of 
hyperglycemia, i.e. the random blood glucose test, 
fasting blood glucose test, or postprandial glucose 
test. Many factors are known to affect blood glucose 
in the diabetic patient, including lifestyle factors such 
as smoking [4]. 
Cigarette smoking is independently 
associated with the incidence of diabetes mellitus 
[5][6]. Smoking-induced oxidative stress might have 
some effect on blood glucose as well as directly alter 
blood glucose homeostasis and cause insulin 
resistance. The exact biological pathway of this theory 
has not been fully elucidated, but it is suspected that 
high concentration of circulating epinephrine and 
norepinephrine due to smoking may contribute to 
hyperglycemia by increasing the rate of hepatic 
gluconeogenesis and glycogenolysis [5] [6] [7]. 
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Another method used to assess blood 
glucose over a longer period is by analysing the 
concentration of glycated haemoglobin (HbA1c). 
HbA1c is a result of non-enzymatic attachment of a 
hexose molecule to the haemoglobin molecule. This 
process occurs continually over the entire lifespan of 
the erythrocyte and is dependent on blood glucose 
concentration and the duration of erythrocyte 
exposure to blood glucose [8]. Therefore, the HbA1c 
reflects the mean glucose concentration over the 
previous period. The international expert committee 
stated that HbA1c could be used as a diagnostic test 
for diabetes [9].
  
Smoking might alter glucose 
homeostasis; it might be as well affecting HbA1c 
concentration [10]. 
This experiment was conducted to assess the 
difference of blood glucose concentration and HbA1c 
among diabetic smoking patient and non-smoking 
diabetic patients. 
 
 
Methods 
 
The protocol of the study was approved by 
the Research Ethics Committee of Faculty of Medicine 
of University of Sumatera Utara (NO: 198/TGL/KEPK 
FK USU-RSUP HAM/2017). 
This study used the cross-sectional approach. The 
study population included diabetic patients 
attending Endocrine Clinic University of Sumatera 
Utara Hospital from June to September 2017. The 
study population consisted of thirty diabetic smoking 
patients and thirty non-smoking diabetic patients. To 
avoid confounding factors, the diabetic patients 
included in this study was in 50-60 years age range 
and has been diagnosed with diabetes for the past 5 
to 10 years.The exclusion criteria were: (1) history of 
using any antioxidant supplement; (2) history of 
current acute or chronic infection; (3) history of 
malignancy; (3) History of red blood cell membrane 
disorder or anaemia.                  
To obtain data on age, duration of diabetes, 
and history of smoking (duration of smoking and 
cigarette per day), a questionnaire-
based interview was used. The biomarker of 
hyperglycemia is, i.e. fasting blood glucose, 
postprandial blood glucose, and the HbA1c level was 
measured by hexokinase and immunoturbidimetry met
hod using Cobas 6000 analyser module c501 (Roche 
Diagnostics, Switzerland). Diabetes patients with 
HbA1c higher than 6.5% were categorised as 
uncontrolled diabetes. All data were processed using 
the statistical package for social science (SPSS). The 
differences among groups were tested by using 
Mann-Whitney, and p-values of < 0.05 were 
considered significant.  
 
Results 
 
This study was carried out among 60 diabetic 
patients attending the endocrine clinic in 
North Sumatera University Hospital from June to 
September 2017. The characteristic of the study 
population is shown in Table 1 below. 
Table 1: Characteristics of the study population 
 Smoking Status  
Total Non-Smokers Smokers 
Sex    
Male 13 (43.33%) 26 (86.67%) 39 (65%) 
Female 17 (56.67%) 4 (13.33% 21 (35%) 
Age 57.7 (± 6) 57 (± 9.9) - 
Duration of Diabetes 7.76 (± 9.26) 7.03(± 6.76) - 
Diabetes Criteria    
Controlled Diabetes 6 (20%) 2 (6.67%) 8 (13.33%) 
Uncontrolled 
Diabetes 
24 (± 80%) 28 (93.33%) 52 (86.67%) 
Duration of Smoking - 29.7(± 10.92)  
Cigarettes Per Day - 15.93 (± 10.24)  
 
Table 1 shows that the study population 
consists of 39 male diabetic patients and 21 female 
diabetic patients. Among 39 male diabetic patients, 26 
were smokers while the other 13 were not. As for 
female patients, 4 were smokers, and 17 were non-
smokers. The mean age of the participant in this study 
is 57.7 for the control group and 57 for the study 
group. Among 60 diabetic patients in this study, 36 of 
them were diagnosed with diabetes during the past 5 
years. Diabetic patients with HbA1c higher than 6.5% 
were categorised as uncontrolled diabetes. Table 1 
showed 52 diabetic patients have uncontrolled 
diabetes. Among the 52 diabetic patients, 24 were a 
non-smoker, and the other 28 were smokers. For the 
smokers group, the average duration of smoking was 
29.7 (± 10.92) years, with average cigarettes per day 
were 15.93 or equivalent to almost 1 pack of 
cigarettes per day.  
The comparison between fasting blood 
glucose, postprandial blood glucose, and HbA1c in 
each study group is shown in Table 2. 
Table 2: Blood glucose level and HbA1c in the studied group 
  
Non-smokers Smokers p 
FBG Min. 94 93 
 
 
Max. 307 486 
 
 
Median 155 177 
 
 
Mean ± SD 170.36 (± 54.74) 194 (± 83.95) 0.325 
PBG Min. 117 130 
 
 
Max. 407 611 
 
 
Median 242 294 
 
 
Mean ± SD 249.67 (± 76.07) 307.67 (± 97.22) 0.016 
HbA1c Min. 5 7 
 
 
Max. 13 12 
 
 
Median 9 9 
 
 
Mean ± SD 8.65 (± 1.91) 9.04 (± 1.53) 0.412 
 
A Higher level of fasting blood glucose was 
observed in the study group compared to the control 
group. The mean difference between groups was 
23.64 mg/dl. The Mann-Whitney test showed p-value 
0.325. There was 58.0 mg/dl difference in 
postprandial glucose between study and control 
group. The Mann-Whitney test showed p-value 0.016. 
HbA1c was 0.39 mmol/mol higher in the study group 
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compared to the control group with p-value 0.412. 
 
 
Discussion 
 
All three chemical biomarkers were higher in 
the smokers group compared to the non-smokers 
group after adjustment for a possible confounding 
variables such as age, diet, physical activity, and 
types of medication used. There was no significant 
difference in fasting blood glucose levels between 
study and control groups. There was also no 
significant difference of HbA1c among the group as 
the independent t-test shows the p-value > 0.05. For 
postprandial glucose, the independent t-test showed 
p-value < 0.05 which means there was a significant 
difference in postprandial glucose between both 
groups.  
The postprandial blood glucose test is used to 
evaluate the ability to regulate glucose metabolism. 
The postprandial glucose test also provides an insight 
on insulin sensitivity. Compared with fasting blood 
glucose and HbA1c cut points, the postprandial 
glucose test value diagnoses more people with 
diabetes [9]. Various studies have demonstrated that 
insulin resistance is dose-dependently related to 
smoking. The level of basal insulin secretion and 
insulin resistance (evaluated by HOMA-IR protocol) 
were higher in smoking compared to non-smoking 
patients [5] [6] [11] [12].
 
The prevalence of type 2 diabetes increases 
with age, and it is also well documented that ageing is 
associated with a decline in insulin action as well as 
pancreas function. Normally, pancreatic beta cells 
have a long lifespan with low proliferation rate; 
however, during increased metabolic demand or after 
injury, adult pancreas could be able to produce new 
cells. As we age, this proliferative capability of 
pancreas declines [13] [14]. Smoking causes oxidative 
stress due to an increase in ROS that found in 
smokers body12] [15]. This condition causes oxidative 
damage such as lipid peroxidation, protein oxidation, 
and DNA damage. The island of the pancreas is 
particularly vulnerable to damage caused by ROS 
accompanied by a lack of antioxidant enzymes in the 
cells. ROS will induce the activation of Poly-ADP-
Ribose-Polymerase (PARP) that causes NAD 
depletion. This will result in the apoptosis of insulin-
producing cells [12].   
There is a clear, dose-dependent relation 
between diabetes or glucose intolerance and both 
active and passive cigarette exposure. Adiponectin 
concentration seems to partially mediate the effect of 
smoking on glucose homeostasis [5] [17] [18]. 
High level of ROS generated by smoking will 
inhibit phosphatidylinositol–3-kinase activity, thus 
decreasing the secretion of adiponectin from adipose 
tissue. This lower concentration of adiponectin is a 
common finding in obese or diabetic patients [18].
 
Adiponectin stimulates the phosphorylation and 
activation of 5′-adenosine monophosphate-
activated protein kinase in the liver and skeletal 
muscles, thereby directly affecting glucose 
homeostasis and insulin sensitivity [5]. 
Another experiment showed how nicotine 
alters glucose metabolism in animal models. The dose 
of nicotine used in this experiment 
was chosen to mirror the average cigarette smokers 
peak blood level of cotinine. Acute nicotine treatment 
for 30 minutes, caused hyperglycemia and glucose 
intolerance. The hyperglycemic effect of acute 
nicotine treatment was mediated by the activation of 
certain nAchR subunit because the 
hyperglycemia was abolished by CSM 
(nAchR inhibitor). This acute nicotine treatment also 
increases both basal insulin secretion, glucose-
stimulated insulin secretion, and decreases insulin 
sensitivity [7]. Furthermore, smokers have been 
shown to have higher fasting plasma cortisol 
concentrations than non-smokers. Higher cortisol 
concentrations may be a consequence of the 
stimulation of sympathetic nervous system activity that 
is induced by smoking, and higher cortisol may lead to 
hyperinsulinemia [11] [17]. 
For HbA1c variable, the result in this 
study was in contrast with a previous study that 
shows HbA1c was higher by 0.08% in smokers 
compared to non–smokers [19].
 
Glycated haemoglobin provides a better indication of 
long-term glycemic control than blood glucose levels. 
During the lifespan of erythrocyte, they are constantly 
exposed to glucose and result in non-enzymatic 
attachment of glucose to the haemoglobin molecule 
within the erythrocyte. Due to the longer lifespan of 
erythrocyte, haemoglobin reflects the mean blood 
glucose over previous periods (approximately 3 
months, as the average lifespan of the erythrocyte is 
120 days). The rate of HbA1c formation is directly 
proportional to the mean of blood glucose during the 
lifespan of the erythrocyte. Due to its 
properties, HbA1c is often used to monitor blood 
glucose in the diabetic patient and also used to 
monitor patient response toward diabetes therapy [9] 
[10]. Many studies have reported the unfavorable 
effects of smoking for diabetes mellitus. Smoking 
increases the risk of developing diabetes, and 
aggravates the micro-and macro-vascular 
complications of diabetes mellitus [6] [9].
 
Diabetic 
patients are also more likely to develop various oral 
health problems that may be aggravated by smoking 
[20]. 
The result in this study did not represent the 
entire smoking and non-smoking diabetic patients due 
to the cross-sectional design and relatively very small 
study population. Future studies are needed to 
analyse the exact biological effect of various factors 
such as types of medication used, physical activity 
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and lifestyle that can affect blood glucose and HbA1c, 
since a substantial portion of HbA1c and blood 
glucose concentration may be determined by these 
non-glycemic factors [10] [15] [21]. 
This study concluded that 
postprandial glucose levels were different in smoking 
compared to non-smoking diabetic patients. Smoking 
may contribute to the development of insulin 
resistance as there were higher postprandial glucose 
levels in smoking diabetic patients compared to the 
non-smoking diabetic patients. Although further 
studies are needed for this specific population 
regarding the impact of smoking on glucose 
metabolism and insulin resistance, smoking cessation 
programs should be offered to the diabetic population. 
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